Alzheimer’s Disease: Pathogenesis and Therapeutic Interventions
- 1 March 2022
- journal article
- Published by Bentham Science Publishers Ltd. in Current Aging Science
- Vol. 15 (1) , 2-25
Abstract
Background: Alzheimer’s Disease (AD) is the most common cause of dementia. Genetics, excessive exposure to environmental pollutants, as well as unhealthy lifestyle practices are often linked to the development of AD. No therapeutic approach has achieved complete success in treating AD; however, early detection and management with appropriate drugs are key to improving prognosis. Interventions: The pathogenesis of AD was extensively discussed in order to understand the reasons for the interventions suggested. The interventions reviewed include the use of different therapeutic agents and approaches, gene therapy, adherence to healthy dietary plans (Mediterranean diet, Okinawan diet and MIND diet), as well as the use of medicinal plants. The potential of nanotechnology as a multidisciplinary and interdisciplinary approach in the design of nano-formulations of AD drugs and the use of Superparamagnetic Iron Oxide Nanoparticles (SPIONs) as theranostic tools for early detection of Alzheimer’s disease were also discussed.Keywords
This publication has 195 references indexed in Scilit:
- Advanced drug delivery systems: Nanotechnology of health design A reviewJournal of Saudi Chemical Society, 2014
- Autosomal Recessive Causes Likely in Early-Onset Alzheimer DiseaseArchives of Neurology, 2012
- Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future DirectionsMolecular Neurobiology, 2011
- Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issuesNanomedicine: Nanotechnology, Biology and Medicine, 2011
- The history of the cholinergic hypothesisBehavioural Brain Research, 2011
- Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseasesTrends in Pharmacological Sciences, 2010
- Is cognitive function linked to serum free copper levels? A cohort study in a normal populationClinical Neurophysiology, 2010
- Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's DiseaseMolecular Therapy, 2010
- Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's diseaseNature Medicine, 2009
- Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOEThe American Journal of Human Genetics, 2008